Discontinuous release of bone morphogenetic protein-2 loaded within interconnected pores of honeycomb-like polycaprolactone scaffold promotes bone healing in a large bone defect of rabbit ulna

Tissue Engineering - Part A

Volumn 17, Issue 19-20, 2011, Pages 2389-2397

  Bae, Ji Hoon ^a   Song, Hae Ryong ^b   Kim, Hak Jun ^b   Lim, Hong Chul ^b   Park, Jung Ho ^a   Liu, Yuchun ^c   Teoh, Swee Hin ^c  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; DEFECTS; HONEYCOMB STRUCTURES; POLYCAPROLACTONE; PROTEINS; RADIOLOGY;

ANIMAL MODEL; BONE DEFECT; BONE FORMATION; BONE HEALING; BONE INGROWTH; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE VOLUME FRACTION; CELLULAR INFILTRATION; DEFECT SITES; HUMAN BONE MORPHOGENETIC PROTEIN; IN-VIVO; INTERCONNECTED PORES; LARGE DEFECTS; MATURE BONE; MICROCOMPUTED TOMOGRAPHY; OSTEOCONDUCTIVE; PILOT STUDIES; PLAIN RADIOGRAPHY; POLYCAPROLACTONE SCAFFOLDS; POROUS NETWORKS; POROUS STRUCTURES; POST-IMPLANTATION; QUANTITATIVE MEASUREMENT; RELEASE PROFILES; REPAIR MECHANISM; RHBMP-2; TRABECULAR THICKNESS; VASCULATURE;

SCAFFOLDS (BIOLOGY);

ANIMALIA; ORYCTOLAGUS CUNICULUS;

BONE MORPHOGENETIC PROTEIN 2; POLYCAPROLACTONE; POLYESTER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; HUMAN; MALE; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; POROSITY; RABBIT; RADIOGRAPHY; ULNA; WOUND HEALING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; HUMANS; MALE; POLYESTERS; POROSITY; RABBITS; RECOMBINANT PROTEINS; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA; ULNA; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 80053093007     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0032     Document Type: Article

References (50)

1. Horner, E.A., Kirkham, J., Wood, D., Curran, S., Smith, M., Thomson, B., et al. Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng Part B Rev 16, 263, 2010.
2. Stevens, B., Yang, Y., Mohandas, A., Stucker, B., and Nguyen, K.T. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J Biomed Mater Res B Appl Biomater 85, 573, 2008.
3. Mastrogiacomo, M., Scaglione, S., Martinetti, R., Dolcini, L., Beltrame, F., Cancedda, R., et al. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 27, 3230, 2006.
4. Muschler, G.F., Nakamoto, C., and Griffith, L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A, 1541, 2004.
5. Owen, M., and Peck, W. Lineage of osteogenic cells and their relationship to the stromal system. In: Bilezikian, J.P., Raisz, L.G., and Rodan, G.A, eds. Principles of Bone Biology, Volume Irvine, CA: Academic Press, 1985, pp. 1-25.
6. Beresford, J.N. Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 270, 1989.
7. Friedenstein, A.J. Precursor cells of mechanocytes. Int Rev Cytol 47, 327, 1976.
8. Southwood, L.L., Frisbie, D.D., Kawcak, C.E., Ghivizzani, S.C., Evans, C.H., McIlwraith, C.W., et al. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res 22, 66, 2004.
9. Southwood, L.L., Frisbie, D.D., Kawcak, C.E., and McIlwraith, C.W. Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg 33, 565, 2004.
10. Karageorgiou, V., Meinel, L., Hofmann, S., Malhotra, A., Volloch, V., Kaplan, D., et al. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71, 528, 2004.
11. Reddi, A.H., and Cunningham, N.S. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8 Suppl 2, S499, 1993.
12. Reddi, A.H. Cell biology and biochemistry of endochondral bone development. Coll Relat Res 1, 209, 1981.
13. Urist, M.R. Bone: formation by autoinduction. 1965. Clin Orthop Relat Res 4, 2002.
14. Urist, M.R., Mikulski, A., and Lietze, A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76, 1828, 1979.
15. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528, 1988.
16. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87, 2220, 1990.
17. Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., Rueger, D.C., Whitecloud, T.S., et al. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76, 827, 1994.
18. Cook, S.D., Baffes, G.C., Wolfe, M.W., Sampath, T.K., and Rueger, D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 302, 1994.
19. Gerhart, T.N., Kirker-Head, C.A., Kriz, M.J., Holtrop, M.E., Hennig, G.E., Hipp, J., et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 317, 1993.
20. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81, 2008.
21. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
22. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
23. Zein, I., Hutmacher, D.W., Tan, K.C., and Teoh, S.H. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials 23, 1169, 2002.
24. Schuckert, K.H., Jopp, S., and Teoh, S.H. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A 15, 493, 2009.
25. Schantz, J.T., Lim, T.C., Ning, C., Teoh, S.H., Tan, K.C., Wang, S.C., et al. Cranioplasty after trephination using a novel biodegradable burr hole cover: technical case report. Neurosurgery 58, ONS, 2006.
26. Endres, M., Hutmacher, D.W., Salgado, A.J., Kaps, C., Ringe, J., Reis, R.L., et al. Osteogenic induction of human bone marrow-derived mesenchymal progenitor cells in novel synthetic polymer-hydrogel matrices. Tissue Eng 9, 689, 2003.
27. Hutmacher, D.W., Schantz, T., Zein, I., Ng, K.W., Teoh, S.H., Tan, K.C., et al. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 55, 203, 2001.
28. Iroh, J., and Mark, J. Poly(epsilon-caprolactone). In: Mark, J.E., ed. Polymer Data Handbook. New York, NY: Oxford University Press Inc., 1999, pp. 361-362.
29. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529, 2000.
30. Rai, B., Teoh, S.H., Hutmacher, D.W., Cao, T., and Ho, K.H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 26, 3739, 2005.
31. Wozney, J.M., and Li, R.H. Engineering what comes naturally. Nat Biotechnol 21, 506, 2003.
32. Ai-Aql, Z.S., Alagl, A.S., Graves, D.T., Gerstenfeld, L.C., and Einhorn, T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87, 107, 2008.
33. Kempen, D.H.R., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
34. Yamamoto, M., Takahashi, Y., and Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375, 2003.
35. Uludag, H., D'Augusta, D., Palmer, R., Timony, G., and Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 46, 193, 1999.
36. Uludag, H., Friess, W., Williams, D., Porter, T., Timony, G., D'Augusta, D., et al. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann N Y Acad Sci 875, 369, 1999.
37. Lee, J., Son, M.J., Woolard, K., Donin, N.M., Li, A., Cheng, C.H., et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69, 2008.
38. Rai, B., Oest, M.E., Dupont, K.M., Ho, K.H., Teoh, S.H., Guldberg, R.E., et al. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A 81, 888, 2007.
39. Narayan, R., ed. Biomedical Materials. Dusseldorf, Germany: Springer Verlag, 2009, 566p.
40. Wise, D.L., ed. Biomaterials Engineering and Devices: Orthopedic, Dental, and Bone Graft Applications. Totowa, NJ: Humana Pr. Inc., 2000.
41. Chen, D., Zhao, M., and Mundy, G.R. Bone morphogenetic proteins. Growth Factors 22, 233, 2004.
42. Onishi, T., Ishidou, Y., Nagamine, T., Yone, K., Imamura, T., Kato, M., et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22, 605, 1998.
43. Ishidou, Y., Kitajima, I., Obama, H., Maruyama, I., Murata, F., Imamura, T., et al. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10, 1651, 1995.
44. Mehlhorn, A.T., Niemeyer, P., Kaschte, K., Muller, L., Finkenzeller, G., Hartl, D., et al. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Prolif 40, 809, 2007.
45. Cook, S.D., Wolfe, M.W., Salkeld, S.L., and Rueger, D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77, 734, 1995.
46. Chu, T.W., Wang, Z.G., Zhu, P.F., Jiao, W.C., Wen, J.L., Gong, S.G., et al. [Effect of vascular endothelial growth factor in fracture healing]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16, 75, 2002.
47. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Ferrara, N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
48. Kanczler, J.M., and Oreffo, R.O.C. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15, 100, 2008.
49. Rai, B., Ho, K.H., Lei, Y., Si-Hoe, K.M., Jeremy Teo, C.M., Yacob, K.B., et al. Polycaprolactone-20% tricalcium phosphate scaffolds in combination with platelet-rich plasma for the treatment of critical-sized defects of the mandible: a pilot study. J Oral Maxillofac Surg 65, 2195, 2007.
50. Rai, B., Teoh, S.H., Ho, K.H., Hutmacher, D.W., Cao, T., Chen, F., et al. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 25, 5499, 2004.